Natera Q4 Earnings Call Highlights [Yahoo! Finance]
Natera, Inc. (NTRA)
Last natera, inc. earnings: 2/26 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.natera.com
Company Research
Source: Yahoo! Finance
units ) and generating roughly $666 million in Q4 revenue , up about 40% year-over-year, with Signatera ASPs near and improved collections (47 DSO) including ~$60 million of revenue true-ups. The company delivered a surprise margin beat with a reported 66.9% gross margin (organic ~63.7%), posted net income in Q4 helped by a one-time tax item, and exited with a strong balance sheet of over $1 billion in cash and securities and $107 million in cash flow for 2025. Natera guided 2026 revenue of $2.62–$2.70 billion with a 63–65% gross margin , plans modest operating expense growth (~9.5% midpoint) while investing in R&D (DEFINE, MRD trials), and highlighted clinical/regulatory progress including a MolDX submission for the tissue-free MRD test Latitude, phased-variant technology launching clinically in 2026, and an expected major Japan launch later in 2026. Interested in Natera, Inc.? Here are five stocks we like better. 3 Under-the-Radar Healthcare Companies Natera (NASDAQ:NTRA)
Show less
Read more
Impact Snapshot
Event Time:
NTRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NTRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NTRA alerts
High impacting Natera, Inc. news events
Weekly update
A roundup of the hottest topics
NTRA
News
- Natera (NTRA) is now covered by William Blair. They set an "outperform" rating on the stock.MarketBeat
- Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics’ MRD-Guided ALPHA3 Trial in Large B-Cell LymphomaBusiness Wire
- Judge Awards 30% Ongoing Royalty to Natera for its MRD-Related PatentsBusiness Wire
- Natera Inc. (NTRA): Upside Potential Pulls Billionaire Stan Druckenmiller [Yahoo! Finance]Yahoo! Finance
- 20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera’s Oncology PlatformBusiness Wire
NTRA
Earnings
- 2/26/26 - Miss
NTRA
Sec Filings
- 4/9/26 - Form 3
- 4/8/26 - Form 4
- 4/3/26 - Form 4
- NTRA's page on the SEC website